Supernus Pharmaceuticals, Inc. (SUPN)

48.10 +0.82 (+1.73%) USD  |  NASDAQ  |  Dec 16, 10:26
More

Supernus Pharmaceuticals Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
CorMedix, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade